FGF23 and chronic kidney disease: High circulating levels of FGF23 are associated with improved indices of skeletal mineralization analyzed by bone biopsy in pediatric patients on chronic peritoneal dialysis [83] but not in another group of pediatric patients with predialysis CKD [86].